Publication Name	World Journal of Diabetes
Manuscript ID	105711
Country	China

Received	2025-02-17 09:49
Peer-Review Started	2025-02-18 00:05
To Make the First Decision
Return for Revision	2025-03-11 06:03
Revised	2025-03-24 11:44
Second Decision	2025-04-18 10:36
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-04-25 07:53
Articles in Press	2025-04-25 07:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-05-27 02:52
Publish the Manuscript Online	2025-06-13 11:47

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Urology & Nephrology
Manuscript Type	Review
Article Title	Progress in the application of mesenchymal stem cells to attenuate apoptosis in diabetic kidney disease
Manuscript Source	Invited Manuscript
All Author List	Ping Nie, Wei Qin, Wei-Chen Nie and Bing Li
ORCID	Author(s) ORCID Number Ping Nie http://orcid.org/0000-0003-2029-4432 Wei Qin http://orcid.org/0009-0009-7467-3367 Wei-Chen Nie http://orcid.org/0009-0004-8091-7528 Bing Li http://orcid.org/0000-0001-7640-9468
Funding Agency and Grant Number	Funding Agency Grant Number Science and Technology Research Program of Jilin Provincial Department of Education JJKH20231218KJ Project of the Jilin Provincial Administration of Traditional Chinese Medicine 2024111
Corresponding Author	Bing Li, Department of Nephropathy, The Second Hospital of Jilin University, No. 218 Ziqiang Street, Changchun 130041, Jilin Province, China. li_bing2020@jlu.edu.cn
Key Words	Apoptosis; Diabetic kidney disease; Mesenchymal stem cells; miRNA; Extracellular vesicles
Core Tip	Diabetic kidney disease (DKD) represents a prevalent and serious complication of diabetes. Mesenchymal stem cells (MSCs) and their extracellular vesicles (MSC-EVs) show promise for treating DKD by regulating apoptosis; however, challenges such as a lack of standardization, hinder their clinical application. This review examines the research progress on the roles of MSCs and MSC-EVs in this disease.
Publish Date	2025-06-13 11:47
Citation	<p>Nie P, Qin W, Nie WC, Li B. Progress in the application of mesenchymal stem cells to attenuate apoptosis in diabetic kidney disease. <i>World J Diabetes</i> 2025; 16(6): 105711</p>
URL	https://www.wjgnet.com/1948-9358/full/v16/i6/105711.htm
DOI	https://dx.doi.org/10.4239/wjd.v16.i6.105711

Full Article (PDF)	WJD-16-105711-with-cover.pdf
Manuscript File	105711_Auto_Edited_080442.docx
Answering Reviewers	105711-answering-reviewers.pdf
Audio Core Tip	105711-audio.mp3
Conflict-of-Interest Disclosure Form	105711-conflict-of-interest-statement.pdf
Copyright License Agreement	105711-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	105711-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	105711-non-native-speakers.pdf
Peer-review Report	105711-peer-reviews.pdf
Journal Editor-in-Chief Review Report	105711-journal-editor-in-chief.pdf
Scientific Misconduct Check	105711-scientific-misconduct-check.png
Scientific Editor Work List	105711-scientific-editor-work-list.pdf
CrossCheck Report	105711-crosscheck-report.pdf